Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › El Paso › NPI 1316936990
Physician

El Paso County Hospital District

El Paso County Hospital District was paid $21.35M by Medicaid between Jan 2018 and Dec 2024, across 293 billing codes. Its largest line is 99285, emergency room visit (most serious) — 17% of everything it billed.

33Billing provider infoEL PASO COUNTY HOSPITAL DISTRICT
EL PASO, TX 79905
33aNPI1316936990assigned 10/17/2005
33bProvider typePediatrics Physician
28Total paid$21.35M
24GClaims550,063
24DCodes billed293
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Pediatrics Physician providers in Texas

Rank by total paid#9 of 1,136
Median peer was paid$329K
This provider vs. median65×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$250K$500K$750K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20188,715$746K
20195,567$1.14M
202027,092$1.25M
2021123,703$3.77M
2022161,364$5.79M
2023143,537$5.97M
2024incomplete80,085$2.70M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 17% 5,377 4,839 $3.63M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 9,829 8,849 $3.29M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 14% 17,627 16,566 $2.91M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 5.0% 28,897 24,731 $1.07M
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 4.6% 31,473 25,444 $972K
G0378 Hospital observation service, per hour 3.4% 2,578 2,338 $730K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.4% 2,011 1,881 $521K
70450 Computed tomography, head or brain; without contrast material 1.7% 2,644 2,420 $358K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.6% 8,569 7,267 $348K
80050 General health panel 1.6% 3,397 3,208 $345K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1.5% 5,396 5,112 $331K
80053 Comprehensive metabolic panel 1.5% 29,825 23,754 $322K
281 more codes
99214 Doctor's office visit, returning patient (more involved) 1.4% 7,542 $302K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.0% 1,975 $223K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.0% 5,172 $222K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1.0% 5,394 $219K
80061 Lipid panel 1.0% 8,565 $218K
86703 1.0% 4,515 $216K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 3,733 $204K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 32,034 $187K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 3,041 $172K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 2,147 $160K
T1015 A visit at a community health center or clinic (one all-in rate) <1% 2,137 $149K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 590 $143K
87081 <1% 6,494 $138K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 5,191 $134K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 1,475 $130K
82652 <1% 2,486 $119K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 1,602 $118K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,172 $115K
83036 Hemoglobin; glycosylated (A1C) <1% 8,664 $107K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,988 $97K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 12,161 $95K
87631 <1% 1,797 $94K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 1,524 $94K
71045 Radiologic examination, chest; single view <1% 4,680 $93K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 5,881 $89K
72125 Computed tomography, cervical spine; without contrast material <1% 767 $86K
90460 Immunization administration through 18 years of age via any route, first or only component <1% 11,617 $74K
87276 <1% 7,841 $73K
96375 Therapeutic injection; each additional sequential IV push <1% 4,237 $68K
71046 Radiologic examination, chest; 2 views <1% 2,618 $68K
80055 <1% 378 $67K
87275 <1% 7,846 $67K
Q3014 Telehealth originating site facility fee <1% 4,247 $65K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 423 $65K
84484 <1% 5,822 $61K
93307 <1% 551 $60K
81001 <1% 12,203 $56K
87086 Culture, bacterial; quantitative colony count, urine <1% 6,155 $55K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 4,712 $54K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 382 $54K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) <1% 866 $49K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 2,610 $46K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,427 $45K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 840 $39K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 1,975 $36K
99204 Doctor's office visit, new patient (more involved) <1% 498 $35K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 506 $33K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,160 $32K
82805 <1% 822 $30K
84439 <1% 2,513 $27K
76830 Ultrasound, transvaginal <1% 256 $27K
81003 <1% 6,154 $26K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 549 $26K
J1650 Injection, enoxaparin sodium, 10 mg <1% 3,246 $25K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 2,154 $25K
77067 Screening mammography, bilateral, including computer-aided detection <1% 845 $25K
84703 <1% 3,414 $24K
88164 <1% 1,357 $24K
76801 <1% 277 $24K
80048 Basic metabolic panel (calcium, ionized) <1% 3,221 $24K
96376 <1% 1,702 $23K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 518 $23K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 224 $23K
82948 <1% 6,922 $22K
97162 <1% 455 $22K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 738 $21K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 558 $21K
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,497 $21K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,538 $21K
84443 Thyroid stimulating hormone (TSH) <1% 3,319 $21K
83880 <1% 1,002 $20K
85610 <1% 4,363 $20K
86850 <1% 1,785 $20K
87430 <1% 2,413 $19K
86803 <1% 2,269 $19K
99070 <1% 67 $18K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 2,333 $17K
76641 <1% 179 $17K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 182 $16K
59025 Fetal non-stress test <1% 796 $16K
83605 <1% 2,040 $15K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 1,845 $15K
73560 <1% 603 $15K
85730 <1% 2,306 $15K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 4,320 $15K
J2270 Injection, morphine sulfate, up to 10 mg <1% 3,230 $15K
71275 Computed tomographic angiography, chest, with contrast material <1% 81 $15K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 201 $14K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 422 $14K
83690 <1% 2,928 $13K
81025 <1% 1,723 $13K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 3,085 $13K
83735 <1% 3,081 $13K
82570 <1% 3,560 $13K
90715 <1% 807 $13K
82043 <1% 3,191 $13K
97163 <1% 257 $12K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 183 $12K
73030 <1% 449 $12K
72131 <1% 112 $12K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,457 $11K
86592 <1% 2,124 $11K
82728 <1% 798 $11K
96361 Intravenous infusion, hydration; each additional hour <1% 1,028 $11K
82950 <1% 392 $11K
86787 <1% 186 $10K
87340 <1% 1,464 $10K
99203 Doctor's office visit, new patient (routine) <1% 156 $10K
87186 <1% 1,892 $9K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 237 $9K
87077 <1% 2,039 $9K
82607 <1% 923 $9K
84702 <1% 898 $9K
82330 <1% 1,114 $9K
73130 <1% 246 $8K
90651 <1% 90 $8K
70498 <1% 49 $8K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 326 $8K
87040 <1% 1,153 $7K
72170 <1% 285 $7K
72100 <1% 208 $7K
J0690 Injection, cefazolin sodium, 500 mg <1% 1,053 $7K
90461 <1% 2,846 $7K
J3490 Unclassified drugs <1% 728 $7K
86140 <1% 1,639 $6K
73630 <1% 229 $6K
90686 <1% 2,689 $6K
86900 <1% 2,227 $6K
86901 <1% 2,223 $6K
0124A <1% 167 $6K
73610 <1% 128 $5K
85651 <1% 1,547 $5K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 40 $4K
85027 <1% 1,194 $4K
96367 <1% 242 $4K
84100 <1% 1,778 $4K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,410 $4K
82746 <1% 462 $4K
J1170 Injection, hydromorphone, up to 4 mg <1% 883 $4K
84481 <1% 295 $4K
97116 <1% 483 $4K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 941 $4K
90656 <1% 329 $4K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 12 $4K
J2469 Injection, palonosetron hcl, 25 mcg <1% 49 $4K
83540 <1% 711 $3K
72128 <1% 28 $3K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,222 $3K
87210 <1% 671 $3K
73090 <1% 85 $3K
99385 <1% 45 $3K
73590 <1% 94 $3K
97535 Self-care/home management training, each 15 minutes <1% 322 $3K
93971 <1% 27 $3K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 106 $3K
83970 <1% 125 $3K
82947 <1% 1,137 $3K
80074 <1% 113 $3K
73110 <1% 79 $3K
86480 <1% 26 $3K
84295 <1% 904 $2K
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment <1% 102 $2K
87220 <1% 660 $2K
84132 <1% 947 $2K
83550 <1% 362 $2K
70496 <1% 16 $2K
97164 <1% 28 $2K
99242 <1% 30 $2K
82435 <1% 889 $2K
87070 <1% 299 $2K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 77 $2K
77066 Tomosynthesis, mammo <1% 33 $2K
J3475 Injection, magnesium sulfate, per 500 mg <1% 142 $2K
94664 <1% 215 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 109 $2K
J2704 Injection, propofol, 10 mg <1% 2,113 $2K
84145 <1% 96 $1K
90674 <1% 28 $1K
82140 <1% 156 $1K
82550 <1% 269 $1K
80069 <1% 229 $1K
70486 <1% 12 $1K
99223 Prolong inpt eval add15 m <1% 13 $1K
94760 <1% 197 $1K
76000 <1% 27 $1K
77080 <1% 79 $974.35
J3370 Injection, vancomycin hcl, 500 mg <1% 16 $927.30
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 19 $917.09
36415 Collection of venous blood by venipuncture <1% 27,493 $909.68
91322 <1% 75 $846.33
76937 <1% 12 $823.39
99239 Hospital discharge day management, more than 30 minutes <1% 12 $815.66
0001A <1% 848 $788.55
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 40 $734.61
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 86 $703.89
77063 Screening digital breast tomosynthesis, bilateral <1% 47 $695.15
83721 <1% 68 $694.42
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 27 $675.55
A9270 Non-covered item or service <1% 1,149 $663.34
86038 <1% 66 $631.75
85018 <1% 287 $587.31
99232 Hospital visit by a doctor, follow-up day <1% 18 $513.22
83525 <1% 14 $491.36
99308 Subsequent nursing facility care, per day, straightforward <1% 26 $490.50
73080 <1% 14 $481.38
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 868 $470.42
J2060 Injection, lorazepam, 2 mg <1% 112 $451.17
J0137 Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mg <1% 37 $442.82
J1790 Injection, droperidol, up to 5 mg <1% 93 $397.60
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 44 $388.16
58300 <1% 12 $360.92
J1940 Injection, furosemide, up to 20 mg <1% 32 $352.03
97597 <1% 62 $345.41
S5551 Insulin, most rapid onset (lispro or aspart); 5 units <1% 89 $320.38
87205 <1% 123 $315.27
J1050 Injection, medroxyprogesterone acetate, 1 mg <1% 27 $313.88
84520 <1% 136 $305.08
99201 <1% 52 $299.51
90680 <1% 236 $269.08
85014 <1% 148 $259.88
Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml <1% 13 $232.44
86696 <1% 13 $212.88
90662 <1% 227 $209.30
90480 <1% 75 $204.60
0011A <1% 22 $200.00
88312 <1% 13 $175.80
80159 <1% 12 $169.30
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg <1% 81 $169.13
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg <1% 90 $167.46
0002A <1% 343 $156.78
86695 <1% 13 $145.14
84156 <1% 57 $142.74
80076 <1% 34 $140.34
82378 <1% 12 $135.72
84550 <1% 54 $130.48
85396 <1% 23 $112.60
83615 <1% 18 $111.18
84146 <1% 19 $106.15
82248 <1% 42 $95.91
J1815 Injection, insulin, per 5 units <1% 892 $95.54
Q2038 Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) <1% 44 $93.26
0003A <1% 13 $91.13
C1769 Guide wire <1% 17 $74.19
85007 <1% 31 $65.08
90756 <1% 29 $64.03
90694 <1% 157 $63.60
82150 <1% 12 $46.79
90633 <1% 207 $46.49
90670 <1% 742 $36.92
90677 <1% 139 $33.92
82270 <1% 12 $29.21
G0009 Administration of pneumococcal vaccine <1% 24 $22.18
G0008 Administration of influenza virus vaccine <1% 757 $10.46
91312 <1% 170 $0.23
91300 <1% 1,076 $0.13
91301 <1% 173 $0.09
90621 <1% 17 $0.01
90734 0% 320 $0.00
90710 0% 88 $0.00
1159F 0% 219 $0.00
1026F 0% 76 $0.00
3078F 0% 117 $0.00
1160F 0% 194 $0.00
90648 0% 59 $0.00
90700 0% 12 $0.00
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 0% 12 $0.00
90649 0% 27 $0.00
3074F 0% 27 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 0% 1,129 $0.00
1170F 0% 64 $0.00
1126F 0% 983 $0.00
90620 0% 53 $0.00
2010F 0% 228 $0.00
90698 0% 212 $0.00
90743 0% 25 $0.00
99024 0% 80 $0.00
3008F 0% 122 $0.00
4010F 0% 74 $0.00
90723 0% 14 $0.00
3075F 0% 15 $0.00
3044F 0% 14 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCINTRON, ROBERT (CEO)
Same official

Other billing entities under CINTRON, ROBERT

Full network →
ProviderLocationPaid
El Paso County Hospital DistrictFabens, TX$150K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.